Increased mortality with intensive control in patients with higher baseline SBP and lower Framingham risk
Journal
Journal of hypertension
Journal Volume
40
Journal Issue
5
Pages
978-984
Date Issued
2022
Author(s)
Abstract
In the Systolic Blood Pressure Intervention Trial (SPRINT), the relative reduction in primary outcome with intensive blood pressure (BP) control was numerically smallest in the highest baseline SBP tertile. In this post hoc analysis of SPRINT, the goal was to explore whether the effects of intensive BP treatment varied among patients with different baseline SBP and cardiovascular risks.
Subjects
antihypertensive agents; blood pressure; cardiovascular diseases; goals; humans; risk factors; BLOOD-PRESSURE PARAMETERS; CARDIOVASCULAR OUTCOMES; HYPERTENSIVE PATIENTS; HEART-FAILURE; MANAGEMENT; SOCIETY; DISEASE; TAIWAN; ADULTS; RANGE
SDGs
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Type
journal article